| Literature DB >> 30827673 |
Abstract
Ubiquitylation is a post-translational modification (PTM) that controls various cellular signaling pathways. It is orchestrated by a three-step enzymatic cascade know as the ubiquitin proteasome system (UPS). E3 ligases dictate the specificity to the substrates, primarily leading to proteasome-dependent degradation. Deregulation of the UPS components by various mechanisms contributes to the pathogenesis of cancer. This review focuses on E3 ligase-substrates pairings that are implicated in B-cell malignancies. Understanding the molecular mechanism of specific E3 ubiquitin ligases will present potential opportunities for the development of targeted therapeutic approaches.Entities:
Mesh:
Substances:
Year: 2019 PMID: 30827673 PMCID: PMC6584052 DOI: 10.1016/j.cellimm.2019.02.004
Source DB: PubMed Journal: Cell Immunol ISSN: 0008-8749 Impact factor: 4.868